![]() |
市場調査レポート
商品コード
1541598
除細動器市場レポート:製品タイプ、エンドユーザー、地域別、2024~2032年Defibrillators Market Report by Product Type (Implantable Defibrillators, External Defibrillators), End-User (Hospitals and Clinics, Prehospital Care Settings, Cardiac Centers, Homecare Settings, and Others), and Region 2024-2032 |
||||||
カスタマイズ可能
|
除細動器市場レポート:製品タイプ、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2~3営業日
|
世界の除細動器市場規模は2023年に54億米ドルに達しました。今後、IMARC Groupは、2024~2032年にかけての成長率(CAGR)は5.6%を示し、2032年には90億米ドルに達すると予測しています。冠動脈疾患や不整脈などの心臓疾患の罹患率の増加、公共のアクセス場所の増加、救急車サービスの増加などが、市場を推進する主要要因となっています。
除細動器は、心臓に電気ショックを与えることで正常な心拍を回復させるように設計された医療機器です。医療訓練を受けていない人でも緊急時に操作できるよう、使いやすく設計されています。心停止(心臓が突然、効果的に拍動しなくなる状態)を伴う緊急事態では極めて重要です。電気ショックを与えることで心臓を正常なリズムに戻し、患者の命を救うことができます。病院、救急車、空港やショッピングモールのような公共の場所で一般的に使用されています。
冠動脈疾患や不整脈などの心臓疾患の発生率の増加が、世界中で除細動器の需要を押し上げています。さらに、ショッピングモール、公園、交通ハブなど、公共の場にアクセスできる場所の増加が市場の成長を後押ししています。さらに、移動中の救急医療を強化するために除細動器を車両に搭載する救急車サービスの増加も、市場にプラスの影響を与えています。これとは別に、スポーツとフィットネス産業の拡大により、ジム、スポーツ施設、レクリエーションエリアでの除細動器の採用が増加しています。さらに、心臓疾患のリスクが高い肥満の急増が市場の成長を後押ししています。
心臓の健康に対する意識の高まり
除細動器の需要は、大衆の間で心臓の健康に対する意識が高まっていることから増加傾向にあります。個人や組織は、突然の心停止(SCA)に伴うリスクをより強く認識するようになっています。このような意識の高まりが、備えに対する積極的なアプローチにつながっています。学校、オフィス、公共スペース、そして家庭でさえも、除細動器をすぐに利用できるようにすることの重要性を認識しつつあります。重要な瞬間に人命を救う可能性が、需要を後押ししています。さらに、教育キャンペーンやトレーニングの取り組みによって除細動器の使用方法が解明され、より身近で使いやすいものとなっています。
高齢化と慢性疾患の増加
世界の人口の高齢化も、除細動器の需要を喚起する重要な要因です。高齢化が進むにつれて、心臓関連の問題のリスクは増大します。さらに、高血圧や糖尿病などの慢性疾患の有病率も急上昇しています。これらの疾患は心臓の問題を引き起こす可能性があるため、除細動器は緊急対応に不可欠な医療機器となっています。医療施設、高齢者向けコミュニティ、在宅ケア・プロバイダーはいずれも、心臓の緊急事態が発生した場合にタイムリーに介入できるよう、除細動器に投資しています。このような人口動態の変化は持続し、除細動器の需要をさらに喚起すると予想されます。
法規制の強化
除細動器の需要を促進する上で、規制の義務化と法規制が極めて重要な役割を果たしています。多くの国や地域では、空港、スポーツ競技場、公共施設など特定の場所に自動体外式除細動器(AED)をすぐに利用できるようにすることを義務付ける法律を実施しています。このような法的枠組みにより、組織はこれらの要件に準拠する必要性が高まっており、除細動器の調達が増加しています。さらに、建設業や製造業など、労働安全衛生基準が高い業界では、コンプライアンスを確保し、職場の安全性を高めるために除細動器に投資しています。法規制と安全規制の融合により、除細動器は緊急対応インフラに不可欠な要素となっています。
The global defibrillators market size reached US$ 5.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. The increasing incidence of heart diseases, such as coronary artery disease and arrhythmias, rising number of public access locations, and the growing number of ambulance services are some of the major factors propelling the market.
Defibrillators are medical devices designed to restore a normal heartbeat by delivering an electrical shock to the heart. They are designed to be user friendly to ensure that people without medical training can also operate them in emergency situations. They are crucial in emergency situations involving cardiac arrest, which is a condition wherein the heart suddenly stops beating effectively. They provide an electrical shock that can jolt the heart back into a normal rhythm, which potentially saves the life of an individual. They are commonly used in hospitals, ambulances, and public places like airports and shopping malls.
Increasing incidence of heart diseases, such as coronary artery disease and arrhythmias, is driving the demand for defibrillators around the world. Moreover, the rising number of public access locations, including malls, parks, and transportation hubs, is favoring the growth of the market. In addition, the growing number of ambulance services that are equipped with defibrillators in vehicles to enhance emergency medical care during transit is influencing the market positively. Apart from this, the expansion of the sports and fitness industry is increasing the adoption of defibrillators in gyms, sports facilities, and recreational areas. Furthermore, the surging prevalence of obesity, which is correlated with a higher risk of cardiac issues, is bolstering the market growth.
Increasing awareness about cardiac health
The demand for defibrillators is on a rise due to the increasing awareness about cardiac health among the masses. Individuals and organizations are becoming more cognizant of the risks associated with sudden cardiac arrest (SCA), which can strike anyone, anywhere. This heightened awareness has led to a proactive approach in preparedness. Schools, offices, public spaces, and even households are recognizing the importance of having defibrillators readily available. The potential to save lives in critical moments has driven the demand. Moreover, educational campaigns and training initiatives have demystified the use of defibrillators, making them more accessible and user-friendly.
Rise in aging population and chronic diseases
The aging population worldwide is another significant factor catalyzing the demand for defibrillators. As people age, the risk of cardiac-related issues increases. Moreover, the surging prevalence of chronic diseases, such as hypertension and diabetes has also risen. These conditions can lead to heart problems, which makes defibrillators a crucial medical device for emergency response. Healthcare facilities, senior living communities, and home care providers are all investing in defibrillators to ensure timely intervention in case of cardiac emergencies. This demographic shift is expected to sustain and further catalyzing the demand for defibrillators.
Growing legislation and regulatory mandates
Regulatory mandates and legislation have played a pivotal role in driving the demand for defibrillators. Many countries and regions have implemented laws requiring specific locations, such as airports, sports stadiums, and public buildings, to have automated external defibrillators (AEDs) readily available. This legal framework has created a compelling need for organizations to comply with these requirements, thus leading to increased procurement of defibrillators. Additionally, industries with high occupational health and safety standards like construction and manufacturing are investing in defibrillators to ensure compliance and enhance workplace safety. The convergence of legislation and safety regulations has made defibrillators an indispensable component of emergency response infrastructure.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, and end-user.
Implantable Defibrillators
Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
External Defibrillators
Manual External Defibrillator
Automated External Defibrillator (AEDs)
Wearable Cardioverter Defibrillator (WCDs)
Automated external defibrillator (AEDs) dominate the market
The report has provided a detailed breakup and analysis of the market based on the product type. This includes implantable defibrillators [transvenous implantable cardioverter defibrillator (T-ICDs), subcutaneous implantable cardioverter defibrillator (S-ICDs), and cardiac resynchronization therapy defibrillator (CRT-D)] and external defibrillators [manual external defibrillator, automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs)]. According to the report, automated external defibrillator (AEDs) represented the largest segment. AEDs are designed to be used by the public and are commonly found in public places like schools, airports, and shopping centers. They come with pre-set energy levels and automated voice instructions, making them user-friendly. They can automatically analyze the heart rhythm of the patients and advise whether a shock is needed, which ensures that the device is not misused.
T-ICDs are inserted into the body via a vein, typically in the upper chest area. They are connected to the heart through leads placed inside the veins. The device continually monitors the rhythm of the heart and automatically administers an electrical shock when it detects dangerous arrhythmias. T-ICDs are commonly used in patients who have had previous episodes of sudden cardiac arrest or are at high risk for it.
Hospitals and Clinics
Prehospital Care Settings
Cardiac Centers
Homecare Settings
Others
Hospitals and clinics hold the largest share in the market
A detailed breakup and analysis of the market based on the end-user has also been provided in the report. This includes hospitals and clinics, prehospital care settings, cardiac centers, homecare settings, and others. According to the report, hospitals and clinics accounted for the largest market share. In hospitals and clinics, defibrillators are a standard part of the medical equipment available for emergency care. Usually, these healthcare settings use manual external defibrillators, which allow medical professionals more control over the treatment process. These devices are often integrated into advanced life-support systems and used in conjunction with other monitoring equipment to provide comprehensive care. The staff in these settings are typically well-trained in the use of these sophisticated devices, which ensures that patients who experience cardiac emergencies have immediate access to potentially life-saving interventions. Hospitals and clinics are controlled environments with skilled personnel and they are often best suited for managing complex or high-risk cardiac events.
Prehospital care settings refer to emergency medical services that are administered before a patient arrives at a hospital. This can include care given by paramedics in ambulances or first responders at the scene of a medical emergency. In these settings, AEDs or portable manual external defibrillators are commonly used. AEDs are especially useful in this context because they can be operated by a broader range of medical personnel and even by bystanders under guidance, allowing for more immediate intervention. Prehospital care providers often receive specialized training in cardiac life support, which includes the effective use of defibrillators.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest defibrillators market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The surging prevalence of cardiovascular-related health issues represents one of the primary factors driving the demand for defibrillators in the North America region. Moreover, the rising public awareness about the risks of sudden cardiac arrest is favoring the growth of the market in the region. Besides this, a well-established healthcare facilities are influencing the market positively in the region.
Asia Pacific is estimated to witness stable growth, owing to ongoing research and development (R&D) projects, government initiatives, integration of advanced technologies, etc.
The leading companies are developing advanced defibrillators that are equipped with real time monitoring and feedback mechanisms to provide instant analysis of a heart rhythm of a patient and offer guidance to the operator, which improves the chances of successful defibrillation. Moreover, key players are introducing defibrillators integrated with touch screen technology, voice-guided prompts, and visual aids to reduce the time it takes to administer life-saving treatment. They are also adopting the usage of wireless connectivity that allows for remote monitoring and data analysis and enables healthcare providers to keep track of device performance and patient data seamlessly, which can be invaluable for post-care assessment and ongoing treatment planning.
Asahi Kasei Zoll Medical Corporation
Biotronik
Boston Scientific Corporation
Koninklijke Philips N.V.
LivaNova PLC
Medtronic Inc.
Nihon Kohden Corporation
Schiller AG
Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
Stryker Corporation
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
In 2020, Koninklijke Philips N.V. announced that its Emergency Care and Resuscitation (ECR) business recommenced the US manufacturing and shipping of external defibrillators.
In 2022, Medtronic Inc. declared that its investigational EV ICD(TM) System - a first-of-its-kind defibrillator with the lead placed under the breastbone, outside of the heart and veins - achieved a defibrillation success rate of 98.7% and met its safety endpoints in a global clinical trial.
In July 2021, Asahi Kasei Zoll Medical Corporation stated that it has received FDA 510(k) clearance to release the TBI Dashboard(TM) feature on its Propaq(R) M monitor and Propaq MD monitor/defibrillator.